SUBSTIPHARM is a pharmaceutical company, founded in August 1995 by Mr Cesar BERTHIER - formerly partner and executive president of PHARMAPHARM Laboratory and GENODEX Laboratory.

SUBSTIPHARM is the independant company which has the largest investments in registration dossiers in France, with the most important portfolio of products pending registration on the one hand, and development on the other hand.